Morning Briefing
Summaries of health policy coverage from major news organizations
Horizon Pharma Stock Tumbles As Relationship With Express Scripts Unravels
The Associated Press: Express Scripts Sues Horizon As Fight Over Prescriptions Grows
Drugmaker Horizon Pharma is questioning its relationship with an Express Scripts business after the pharmacy benefits giant sued Horizon for about $140 million and dumped a pharmacy that dispenses its drugs. Shares of Horizon Pharma plunged Wednesday after it said it would reevaluate its relationship with the Express Scripts Accredo specialty pharmacy, which accounts for a bigger slice of Horizon's revenue than any other pharmacy. (11/11)
The Wall Street Journal: Horizon Pharma Responds To Express Scripts As Stock Tumbles
Horizon Pharma PLC on Wednesday fired back a response at Express Scripts Holding Co.’s business practices after the largest U.S. pharmacy-benefit manager said it was cutting off a pharmacy that sold medications made by the biopharmaceutical company. “Our philosophy of ensuring that patients get the medicine their doctors prescribe is threatening Express Scripts’ profiteering and exposing what we believe is a lack of care for patients and respect for physicians,” said Chief Executive Timothy P. Walbert. (Steele, 11/11)
Meanwhile, Turing Pharmaceuticals exec Martin Shkreli -- one of the key players in the ongoing debate about drug-pricing practices -- continues to draw headlines -
STAT: The Martin Skhreli Show: The Widely Scorned Pharma Exec Who Just Can't Stop Talking
Martin Shkreli wants you to see him in a funny hat.And playing a video game at the office. And hanging out at home, wearing what look like pajamas. (Robbins, 11/12)
